Insider Trades41 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Sell | CHYM | Adam B Frankel | General Counsel | 3,000 | $17.50 | $8.5B | -42.25% | +40.62% | $52.5K | -0.98% | — | — |
| Jun 9, 2026 | Sell | CHYM | Adam B Frankel | General Counsel | 3,000 | $18.00 | $8.5B | -42.25% | +40.62% | $54.0K | -0.97% | — | — |
| May 15, 2026 | Sell | CHYM | Ryan A King | Co-Founder | 19,147 | $3.91 | $8.5B | -42.25% | +40.62% | $74.9K | -1.37% | — | — |
| May 15, 2026 | Sell | CHYM | Christopher R Britt | Chief Executive Officer | 37,914 | $4.32 | $8.5B | -42.25% | +40.62% | $164.0K | -1.51% | — | — |
| May 15, 2026 | Sell | CHYM | Amine Asmerom | Chief Accounting Officer | 11,791 | $17.88 | $8.5B | -42.25% | +40.62% | $210.8K | -4.74% | — | — |
| May 15, 2026 | Sell | CHYM | Adam B Frankel | General Counsel | 12,438 | $17.88 | $8.5B | -42.25% | +40.62% | $222.4K | -3.86% | — | — |
| May 15, 2026 | Sell | CHYM | Matthew S Newcomb | Chief Financial Officer | 53,887 | $6.10 | $8.5B | -42.25% | +40.62% | $328.8K | -0.56% | — | — |
| May 15, 2026 | Sell | CHYM | Mark T Troughton | President | 26,069 | $17.88 | $8.5B | -42.25% | +40.62% | $466.1K | -0.90% | — | — |
| Feb 17, 2026 | Sell | CHYM | Ryan A King | Co-Founder | 18,813 | $4.73 | $8.5B | -42.25% | +40.62% | $89.0K | -1.41% | — | — |
| Feb 17, 2026 | Sell | CHYM | Adam B Frankel | General Counsel | 9,187 | $19.69 | $8.5B | -42.25% | +40.62% | $180.9K | -4.20% | — | — |
| Feb 17, 2026 | Sell | CHYM | Christopher R Britt | Chief Executive Officer | 37,588 | $4.97 | $8.5B | -42.25% | +40.62% | $186.9K | -1.48% | — | — |
| Feb 17, 2026 | Sell | CHYM | Amine Asmerom | Chief Accounting Officer | 10,957 | $19.69 | $8.5B | -42.25% | +40.62% | $215.7K | -4.93% | — | — |
| Feb 17, 2026 | Sell | CHYM | Mark T Troughton | President | 20,037 | $19.69 | $8.5B | -42.25% | +40.62% | $394.5K | -0.74% | — | — |
| Feb 17, 2026 | Sell | CHYM | Matthew S Newcomb | Chief Financial Officer | 69,039 | $6.84 | $8.5B | -42.25% | +40.62% | $472.4K | -0.78% | — | — |
| Jan 9, 2026 | Sell | CHYM | Adam B Frankel | General Counsel | 1,000 | $22.28 | $8.5B | -42.25% | +40.62% | $22.3K | +0.00% | 10b5-1 | — |
| Jan 9, 2026 | Sell | CHYM | Matthew S Newcomb | Chief Financial Officer | 10,000 | $28.01 | $8.5B | -42.25% | +40.62% | $280.1K | -0.44% | 10b5-1 | — |
| Jan 9, 2026 | Sell | CHYM | Christopher R Britt | Chief Executive Officer | 50,000 | $28.06 | $8.5B | -42.25% | +40.62% | $1.4M | -0.30% | 10b5-1 | — |
| Jan 8, 2026 | Buy | CHYM | Adam B Frankel | General Counsel | 13,731 | $19.98 | $8.5B | -42.25% | +40.62% | $274.4K | +0.71% | 10b5-1 | — |
| Dec 15, 2025 | Sell | CHYM | Mark T Troughton | President | 9,522 | $26.19 | $8.5B | -42.25% | +40.62% | $249.4K | -0.35% | — | — |
| Dec 11, 2025 | Sell | CHYM | Adam B Frankel | General Counsel | 1,000 | $21.78 | $8.5B | -42.25% | +40.62% | $21.8K | +0.00% | 10b5-1 | — |
| Dec 10, 2025 | Buy | CHYM | Adam B Frankel | General Counsel | 4,000 | $18.80 | $8.5B | -42.25% | +40.62% | $75.2K | +0.09% | 10b5-1 | — |
| Dec 8, 2025 | Sell | CHYM | Adam B Frankel | General Counsel | 12,760 | $20.42 | $8.5B | -42.25% | +40.62% | $260.5K | -0.09% | 10b5-1 | — |
| Nov 26, 2025 | Sell | CHYM | Amine Asmerom | Chief Accounting Officer | 84,589 | $20.16 | $8.5B | -42.25% | +40.62% | $1.7M | -15.01% | 10b5-1 | — |
| Nov 20, 2025 | Sell | CHYM | Ryan A King | Co-Founder | 49,125 | $1.57 | $8.5B | -42.25% | +40.62% | $76.9K | -1.18% | — | — |
| Nov 20, 2025 | Sell | CHYM | Mark T Troughton | Chief Operating Officer | 7,407 | $18.43 | $8.5B | -42.25% | +40.62% | $136.5K | -0.28% | — | — |
| Nov 20, 2025 | Sell | CHYM | Adam B Frankel | General Counsel | 10,103 | $18.43 | $8.5B | -42.25% | +40.62% | $186.2K | -3.87% | — | — |
| Nov 20, 2025 | Sell | CHYM | Amine Asmerom | Chief Accounting Officer | 10,577 | $18.43 | $8.5B | -42.25% | +40.62% | $194.9K | -3.33% | — | — |
| Nov 20, 2025 | Sell | CHYM | Christopher R Britt | Chief Executive Officer | 90,154 | $2.59 | $8.5B | -42.25% | +40.62% | $233.7K | -1.81% | — | — |
| Nov 20, 2025 | Sell | CHYM | Matthew S Newcomb | Chief Financial Officer | 219,740 | $1.16 | $8.5B | -42.25% | +40.62% | $256.0K | -0.43% | — | — |
| Sep 8, 2025 | Sell | CHYM | Ryan A King | Co-Founder | 4,175 | $24.34 | $8.5B | -42.25% | +40.62% | $101.6K | -2.29% | — | — |
| Sep 8, 2025 | Sell | CHYM | Amine Asmerom | Chief Accounting Officer | 7,624 | $24.34 | $8.5B | -42.25% | +40.62% | $185.6K | -3.29% | — | — |
| Sep 8, 2025 | Sell | CHYM | Adam B Frankel | General Counsel | 10,103 | $24.34 | $8.5B | -42.25% | +40.62% | $245.9K | -3.72% | — | — |
| Sep 8, 2025 | Sell | CHYM | Christopher R Britt | Chief Executive Officer | 10,778 | $24.34 | $8.5B | -42.25% | +40.62% | $262.3K | -2.93% | — | — |
| Sep 8, 2025 | Sell | CHYM | Matthew S Newcomb | Chief Financial Officer | 13,887 | $24.34 | $8.5B | -42.25% | +40.62% | $338.0K | -2.52% | — | — |
| Sep 8, 2025 | Sell | CHYM | Mark T Troughton | Chief Operating Officer | 16,929 | $24.34 | $8.5B | -42.25% | +40.62% | $412.1K | -0.64% | — | — |
| Jun 12, 2025 | Sell | CHYM | Ryan A King | Co-Founder | 4,175 | $27.00 | $8.5B | -42.25% | +40.62% | $112.7K | -0.02% | — | — |
| Jun 12, 2025 | Sell | CHYM | Christopher R Britt | CHIEF EXECUTIVE OFFICER | 8,431 | $27.00 | $8.5B | -42.25% | +40.62% | $227.6K | -0.04% | — | — |
| Jun 12, 2025 | Sell | CHYM | Adam B Frankel | GENERAL COUNSEL | 46,918 | $27.00 | $8.5B | -42.25% | +40.62% | $1.3M | -4.91% | — | — |
| Jun 12, 2025 | Sell | CHYM | Matthew S Newcomb | CHIEF FINANCIAL OFFICER | 78,419 | $27.00 | $8.5B | -42.25% | +40.62% | $2.1M | -3.39% | — | — |
| Jun 12, 2025 | Sell | CHYM | Mark T Troughton | CHIEF OPERATING OFFICER | 103,678 | $27.00 | $8.5B | -42.25% | +40.62% | $2.8M | -2.20% | — | — |
| Jun 12, 2025 | Sell | CHYM | Amine Asmerom | CHIEF ACCOUNTING OFFICER | 118,143 | $27.00 | $8.5B | -42.25% | +40.62% | $3.2M | -32.81% | — | — |